Immunopolarization of CD4+ and CD8+ T Cells to Type-1–Like is Associated with Melanocyte Loss in Human Vitiligo-Reference-Cited by-同舟云学术

Immunopolarization of CD4+ and CD8+ T Cells to Type-1–Like is Associated with Melanocyte Loss in Human Vitiligo

Published:2003-05 Issue:5 Volume:83 Page:683-695
ISSN:0023-6837
Container-title:Laboratory Investigation
language:
Short-container-title:Lab Invest

Author:

Wańkowicz-Kalińska Anna,van den Wijngaard René M J G J,Tigges Bert J,Westerhof Wiete,Ogg Graham S,Cerundolo Vincenzo,Storkus Walter J,Das Pranab K

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo

2. Bos JD, Zonneveld I, Das PK, Krieg SR, van der Loos CM, Kapsenberg ML and. 1987 The skin immune system (SIS): Distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol 569–573.

3. Transgenic Mice Expressing IFN-γ in the Epidermis Have Eczema, Hair Hypopigmentation, and Hair Loss

4. Type 1 and Type 2: a fundamental dichotomy for all T-cell subsets

5. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyphenols targeting multiple molecular targets and pathways for the treatment of vitiligo;Frontiers in Immunology;2024-07-25

2. Analysis of granulysin expression in vitiligo and halo-nevus;Scientific Reports;2024-07-17

3. Tumor Necrosis Factor-Alpha: Ally and Enemy in Protean Cutaneous Sceneries;International Journal of Molecular Sciences;2024-07-16

4. Differential expression of serum CXCL9 and CXCL10 levels in vitiligo patients and their correlation with disease severity and stability: A cross-sectional study;Indian Journal of Dermatology, Venereology and Leprology;2024-07-03

5. Gut-tropic T cells and extra-intestinal autoimmune diseases;Autoimmunity Reviews;2024-07